We are live on ! Find out more
UPH.WS

UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS

Delisted

UPH.WS was delisted on the 27th of November, 2023.

Back to rankings

1 hedge funds and large institutions have $62 invested in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Skaana Management
New York
$62 – – –

UPH.WS Hedge Fund Activity: Q4 2025 in Review

1 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) for Q4 2025, worth a combined $62.

Fund positioning in UPH.WS was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $62 of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share stock for Q4 2025.
  • 0 funds opened new UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share positions in Q4 2025 and 0 closed out.

Based on aggregated 13F filings for Q4 2025.